Article
Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET trial.
Thrombosis and haemostasis - 1 Aug 2014
Diodati J G, Saucedo J F, Cardillo T E, Jakubowski J A, Henneges C, Effron M B, Lipkin F R, Walker J R, Duvvuru S, Sundseth S S, Fisher H N, Angiolillo D J
Abstract excerpt
High on-treatment platelet reactivity (HPR) has been identified as an independent risk factor for ischaemic events. The randomised, double-blind, TRIPLET trial included a pre-defined comparison of HPR in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) fo...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.